JP2019022828A - 細胞外マトリックス材料から生理活性ゲルを製造する方法 - Google Patents
細胞外マトリックス材料から生理活性ゲルを製造する方法 Download PDFInfo
- Publication number
- JP2019022828A JP2019022828A JP2018218486A JP2018218486A JP2019022828A JP 2019022828 A JP2019022828 A JP 2019022828A JP 2018218486 A JP2018218486 A JP 2018218486A JP 2018218486 A JP2018218486 A JP 2018218486A JP 2019022828 A JP2019022828 A JP 2019022828A
- Authority
- JP
- Japan
- Prior art keywords
- extracellular matrix
- matrix material
- solubilized
- gel
- naoh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
【解決手段】本発明は、ECM材料から生理活性ゲル、すなわち、生理活性を保ち、かつ前臨床及び臨床組織工学並びに組織再建への再生医療アプローチのための足場として働くことのできるゲルを製造する方法を対象とする。本製造方法は、アルカリ性環境で微粒子化されたECM材料を消化し、中和して生理活性ゲルを得ることにより、ECM材料からの生理活性ゲルを作製できるという新しい認識を利用している。
【選択図】 図1
Description
下記の例証では、例えば分離された膀胱粘膜下組織、小腸粘膜下組織、真皮のうちの1つ又は複数などの、ただしこれらに限定されない任意の数のECM製品を使用できる。下記の例証では、膀胱から分離され、上皮基底膜を有するECMであるUBMが、代表的なECMとして使用される。しかし、本明細書で開示される発明はUBMに限定されず、任意の分離されたECMに適用可能である。
Claims (15)
- 細胞外マトリックス材料から生理活性ゲルを製造する方法であって、
a)哺乳動物組織に由来し、天然型の前記組織で見出される量で配置されている、細胞外マトリックス材料の生理活性成分を含む、細胞外マトリックス材料を用意することと、
b)a)の前記細胞外マトリックス材料を微粒子化することと、
c)b)の前記微粒子化された細胞外マトリックス材料を、アルカリ性溶液中で可溶化することと、
d)酸の添加により、工程c)の前記溶液を中和することと
を含む、方法。 - e)工程d)で調製された、前記可溶化され中和された細胞外マトリックス材料を凍結することと、
f)工程e)で調製された、前記凍結した材料を凍結乾燥することと
を更に含む、請求項1に記載の方法。 - 前記凍結乾燥したゲルを水溶液中で戻すことを更に含む、請求項2に記載の方法。
- 工程d)の後、4℃で最大48時間の滞留時間を更に含む、請求項1に記載の方法。
- 工程c)の時間が、30分〜48時間、及び3〜7日間からなる群から選択される、請求項1に記載の方法。
- 前記細胞外マトリックス材料が、小腸粘膜下組織、膀胱粘膜下組織、上皮基底膜を含む膀胱マトリックス、及び肝臓基底膜からなる群に由来する、請求項1に記載の方法。
- 前記微粒子化された細胞外マトリックス材料の粒子範囲サイズが、1μm〜約1000μmである、請求項1に記載の方法。
- 前記細胞外マトリックス材料が、モル濃度範囲約0.1M〜約1.0MのNaOH中に、微粒子化された細胞外マトリックス材料の濃度約0.5%〜11%w/vで可溶化される、請求項1に記載の方法。
- 前記可溶化された細胞外マトリックス材料が、塩酸中で中和される、請求項1に記載の方法。
- 前記塩酸が、0.1M〜1.0Mの濃度を含む、請求項9に記載の方法。
- 前記生理活性成分が、FGF−2、CTGF及びVEGFからなる群から選択される、請求項1に記載の方法。
- 前記細胞外マトリックスが2時間を超えて可溶化される際、前記可溶化された細胞外マトリックス材料中の前記FGF−2の濃度が、前記細胞外マトリックス材料が1.0MのNaOH中に可溶化される場合、100mMのNaOH中に可溶化される場合よりも高い、請求項11に記載の方法。
- 前記細胞外マトリックス材料が2時間を超えて可溶化される際、前記可溶化された細胞外マトリックス材料中の前記VEGFの濃度が、前記細胞外マトリックス材料が1.0MのNaOH中に可溶化される場合、100mMのNaOH中に可溶化される場合よりも高い、請求項11に記載の方法。
- 前記微粒子化された細胞外マトリックス材料がUBMを含み、前記UBMが、100mMのNaOH中に、微粒子化されたUBMの濃度7%で、4℃で24時間可溶化される、請求項1に記載の方法。
- 工程(b)の前記微粒子化された材料が、200〜700ミクロンの範囲にある、請求項1に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361762437P | 2013-02-08 | 2013-02-08 | |
US61/762,437 | 2013-02-08 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017119295A Division JP6622253B2 (ja) | 2013-02-08 | 2017-06-19 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020137567A Division JP2020185450A (ja) | 2013-02-08 | 2020-08-17 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2019022828A true JP2019022828A (ja) | 2019-02-14 |
Family
ID=50238445
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015557083A Expired - Fee Related JP6164782B2 (ja) | 2013-02-08 | 2014-02-07 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
JP2017119295A Expired - Fee Related JP6622253B2 (ja) | 2013-02-08 | 2017-06-19 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
JP2018218486A Pending JP2019022828A (ja) | 2013-02-08 | 2018-11-21 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
JP2020137567A Pending JP2020185450A (ja) | 2013-02-08 | 2020-08-17 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015557083A Expired - Fee Related JP6164782B2 (ja) | 2013-02-08 | 2014-02-07 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
JP2017119295A Expired - Fee Related JP6622253B2 (ja) | 2013-02-08 | 2017-06-19 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020137567A Pending JP2020185450A (ja) | 2013-02-08 | 2020-08-17 | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
Country Status (10)
Country | Link |
---|---|
US (7) | US8802436B1 (ja) |
EP (2) | EP3610895A1 (ja) |
JP (4) | JP6164782B2 (ja) |
KR (5) | KR101874819B1 (ja) |
AU (2) | AU2014214819B2 (ja) |
CA (1) | CA2899931C (ja) |
DK (1) | DK2953659T3 (ja) |
ES (1) | ES2764146T3 (ja) |
HK (1) | HK1218887A1 (ja) |
WO (1) | WO2014124203A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020185450A (ja) * | 2013-02-08 | 2020-11-19 | アセル,インコーポレイテッド | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008109407A2 (en) | 2007-03-02 | 2008-09-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Extracellular matrix-derived gels and related methods |
HUE033504T2 (en) | 2008-09-30 | 2017-12-28 | Univ California | Compositions comprising a decellularized extracellular matrix extracted from cardiac tissue |
WO2012027514A2 (en) | 2010-08-24 | 2012-03-01 | The Regents Of The University Of California | Compositions and methods for cardiac therapy |
EP3119448B1 (en) | 2014-03-21 | 2020-04-22 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix |
JP6499278B2 (ja) * | 2014-09-25 | 2019-04-10 | アセル,インコーポレイテッド | 細胞外マトリックス由来の多孔質フォーム、多孔質フォームecm医療装置、並びに、それらの使用及び製造方法 |
US20160303281A1 (en) | 2015-04-17 | 2016-10-20 | Rochal Industries, Llc | Composition and kits for pseudoplastic microgel matrices |
CA3017747A1 (en) | 2016-03-14 | 2017-09-21 | Regentys Corporation | Method and composition for treating inflammatory bowel disease |
US10150115B2 (en) * | 2016-07-21 | 2018-12-11 | Spacepharma SA | System and method for rehydrating powder and delivering the rehydrated powder to a reactor |
ES2931299T3 (es) | 2017-03-02 | 2022-12-28 | Univ Pittsburgh Commonwealth Sys Higher Education | Hidrogel de matriz extracelular (ECM) y fracción soluble del mismo para su utilización en el tratamiento del cáncer |
ES2957291T3 (es) | 2017-03-02 | 2024-01-16 | Univ Pittsburgh Commonwealth Sys Higher Education | Hidrogel de ECM para el tratamiento de la inflamación esofágica |
WO2018183181A1 (en) * | 2017-03-31 | 2018-10-04 | Acell, Inc. | Extracellular matrix compositions with bactericidal or bacteriostatic characteristics useful for protecting and treating patients with bacterial infections |
CA3067558A1 (en) | 2017-06-16 | 2018-12-20 | Avery Therapeutics, Inc. | Three dimensional tissue compositions and methods of use |
WO2020081604A2 (en) * | 2018-10-15 | 2020-04-23 | Avery Therapeutics, Inc. | Cell-free compositions and methods for restoration or enhancement of tissue function |
WO2021138399A1 (en) * | 2019-12-30 | 2021-07-08 | Renerva, Llc | Extracellular matrix systems, devices, and methods of deployment |
US11826490B1 (en) | 2020-12-29 | 2023-11-28 | Acell, Inc. | Extracellular matrix sheet devices with improved mechanical properties and method of making |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
US5281422A (en) | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
US5800537A (en) | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
US5554389A (en) | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
DE19908318A1 (de) * | 1999-02-26 | 2000-08-31 | Michael Hoffmann | Hämokompatible Oberflächen und Verfahren zu deren Herstellung |
US6579538B1 (en) | 1999-12-22 | 2003-06-17 | Acell, Inc. | Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof |
US6576265B1 (en) | 1999-12-22 | 2003-06-10 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
NZ536564A (en) * | 2002-05-02 | 2008-05-30 | Purdue Research Foundation | Vascularization enhanced graft constructs which comprise a matrix composition consisting of liver basement membrane |
DE112004001553T5 (de) * | 2003-08-25 | 2006-08-10 | Cook Biotech, Inc., West Lafayette | Verpflanzungsmaterialien, die bioaktive Substanzen enthalten, und Methoden zu deren Herstellung |
US8741352B2 (en) * | 2003-08-25 | 2014-06-03 | Cook Biotech Incorporated | Graft materials containing ECM components, and methods for their manufacture |
EP1833384B1 (en) * | 2004-12-30 | 2017-08-16 | Cook Medical Technologies LLC | Inverting occlusion devices and systems |
US9138445B2 (en) * | 2005-03-09 | 2015-09-22 | Cook Biotech Incorporated | Medical graft materials with adherent extracellular matrix fibrous mass |
US8568761B2 (en) * | 2005-07-15 | 2013-10-29 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
US20070027460A1 (en) * | 2005-07-27 | 2007-02-01 | Cook Incorporated | Implantable remodelable materials comprising magnetic material |
WO2007016251A2 (en) * | 2005-07-28 | 2007-02-08 | Cook Incorporated | Implantable thromboresistant valve |
US20070269476A1 (en) * | 2006-05-16 | 2007-11-22 | Voytik-Harbin Sherry L | Engineered extracellular matrices control stem cell behavior |
WO2008060377A2 (en) * | 2006-10-04 | 2008-05-22 | Anthrogenesis Corporation | Placental or umbilical cord tissue compositions |
JP5769925B2 (ja) * | 2006-10-06 | 2015-08-26 | アントフロゲネシス コーポレーション | ヒト胎盤コラーゲン組成物、並びにそれらの製造方法及び使用方法 |
US8343536B2 (en) * | 2007-01-25 | 2013-01-01 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
WO2008109407A2 (en) * | 2007-03-02 | 2008-09-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Extracellular matrix-derived gels and related methods |
WO2009086499A2 (en) | 2007-12-28 | 2009-07-09 | Cook Biotech Incorporated | Medical composition including an extracellular matrix particulate |
US8652500B2 (en) * | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
MX354068B (es) * | 2010-01-14 | 2018-02-09 | Organogenesis Inc | Construcciones de tejido bio-diseñadas por ingenieria y metodos para la produccion y uso de las mismas. |
US9687764B2 (en) | 2012-12-20 | 2017-06-27 | Haier Us Appliance Solutions, Inc. | Filter with audible notification features |
US20140174980A1 (en) | 2012-12-24 | 2014-06-26 | Exxonmobil Research And Engineering Company | Hydrotreated hydrocarbon tar, fuel oil composition, and process for making |
KR101874819B1 (ko) * | 2013-02-08 | 2018-07-05 | 아셀, 인크. | 세포외 기질 재료로부터의 생리활성 조직 손상 치료 재료 |
-
2014
- 2014-02-07 KR KR1020177016009A patent/KR101874819B1/ko active Application Filing
- 2014-02-07 AU AU2014214819A patent/AU2014214819B2/en not_active Ceased
- 2014-02-07 DK DK14708706T patent/DK2953659T3/da active
- 2014-02-07 CA CA2899931A patent/CA2899931C/en active Active
- 2014-02-07 WO PCT/US2014/015214 patent/WO2014124203A1/en active Application Filing
- 2014-02-07 EP EP19201759.8A patent/EP3610895A1/en not_active Withdrawn
- 2014-02-07 KR KR1020187018136A patent/KR20180074818A/ko active Application Filing
- 2014-02-07 ES ES14708706T patent/ES2764146T3/es active Active
- 2014-02-07 KR KR1020207010159A patent/KR102223440B1/ko active IP Right Grant
- 2014-02-07 EP EP14708706.8A patent/EP2953659B1/en active Active
- 2014-02-07 KR KR1020157021086A patent/KR101750349B1/ko active IP Right Grant
- 2014-02-07 US US14/174,980 patent/US8802436B1/en active Active
- 2014-02-07 JP JP2015557083A patent/JP6164782B2/ja not_active Expired - Fee Related
- 2014-02-07 US US14/174,996 patent/US20140227364A1/en not_active Abandoned
- 2014-02-07 KR KR1020197023258A patent/KR102101689B1/ko active Application Filing
- 2014-07-16 US US14/332,465 patent/US9119831B2/en active Active
-
2015
- 2015-07-29 US US14/811,993 patent/US9238091B2/en active Active
- 2015-12-15 US US14/969,800 patent/US9474829B2/en active Active
-
2016
- 2016-06-15 HK HK16106894.6A patent/HK1218887A1/zh not_active IP Right Cessation
- 2016-10-11 US US15/290,445 patent/US9795713B2/en active Active
-
2017
- 2017-06-13 AU AU2017203983A patent/AU2017203983B2/en not_active Ceased
- 2017-06-19 JP JP2017119295A patent/JP6622253B2/ja not_active Expired - Fee Related
- 2017-10-02 US US15/722,312 patent/US20180043057A1/en not_active Abandoned
-
2018
- 2018-11-21 JP JP2018218486A patent/JP2019022828A/ja active Pending
-
2020
- 2020-08-17 JP JP2020137567A patent/JP2020185450A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020185450A (ja) * | 2013-02-08 | 2020-11-19 | アセル,インコーポレイテッド | 細胞外マトリックス材料から生理活性ゲルを製造する方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6622253B2 (ja) | 細胞外マトリックス材料から生理活性ゲルを製造する方法 | |
ES2443045T3 (es) | Hidrogeles de fibroína de seda y usos de éstos | |
US9655948B1 (en) | Non-surgical, localized delivery of compositions for placental growth factors | |
JP2021522938A (ja) | 細胞及び組織の送達のためのナノファイバー−ハイドロゲル複合体 | |
AU2017378904A1 (en) | Injectable hydrogels and applications thereof | |
TW201900185A (zh) | 新穎的再吸收性生物可降解醫藥及化粧品組合物 | |
KR101590313B1 (ko) | 콜라겐으로 구성된 주입형 피하조직재생용 바이오소재 | |
Gold | Development of an Injectable, Cellulose-Based Hydrogel System for Soft Tissue Reconstruction | |
Kentner et al. | Methods of manufacturing bioactive gels from extracellular matrix material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181122 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181220 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181220 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191025 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200124 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200416 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200817 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200821 |
|
C116 | Written invitation by the chief administrative judge to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C116 Effective date: 20200827 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20200827 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20210819 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20211006 |
|
C141 | Inquiry by the administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C141 Effective date: 20211006 |
|
C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20220204 |
|
C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20220302 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20220302 |